Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine

Nature Medicine volume 9, pages 13–14 (2003)Cite this article

A vaccine that is able to work as a treatment for HIV-infected patients has been an elusive goal. Now experiments on macaques suggest that injections of modified dendritic cells might boost immunity to hold back disease progression (pages 27–32).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Human dendritic cell containing HIV-1.

Courtesy of Marie Larsson

References

  1. Rosenberg, E.S. et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523–526 (2000).

    Article  CAS  Google Scholar 

  2. Altfeld, M. et al. HIV-1 superinfection despite broad CD8+ T cell responses containing replication of the primary virus. Nature 420, 434–439 (2002).

    Article  CAS  Google Scholar 

  3. Oxenius, A. et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. USA 99, 13747–13752 (2002).

    Article  CAS  Google Scholar 

  4. Lu, W., Wu, X., Lu, Y., Weizhong, G. & Andrieu, J. Therapeutic dendritic-cell vaccine for simian AIDS. Nature Med. 9, 27–32 (2003).

    Article  CAS  Google Scholar 

  5. Schmitz, J.E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860 (1999).

    Article  CAS  Google Scholar 

  6. Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991–998 (1999).

    Article  CAS  Google Scholar 

  7. Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447–1450 (1997).

    Article  CAS  Google Scholar 

  8. Parren, P.W., Moore, J.P., Burton, D.R. & Sattentau, Q.J. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity. Aids 13 (Suppl. A), S137–162 (1999).

    CAS  PubMed  Google Scholar 

  9. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).

    Article  CAS  Google Scholar 

  10. Rossio, J.L. et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72, 7992–8001 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Bender, A., Bui, L.K., Feldman, M.A., Larsson, M. & Bhardwaj, N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 182, 1663–1671 (1995).

    Article  CAS  Google Scholar 

  12. Bhardwaj, N., Young, J.W., Nisanian, A.J., Baggers, J. & Steinman, R.M. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178, 633–642 (1993).

    Article  CAS  Google Scholar 

  13. Dhodapkar, M.V. et al. Rapid generation of broad T-cell immunity in humans after a single injection of maturation dendritic cells. J. Clin. Invest. 104, 173–180 (1999).

    Article  CAS  Google Scholar 

  14. Ludewig, B. et al. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163, 1839–1844 (1999).

    CAS  PubMed  Google Scholar 

  15. Altfeld, M. et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193, 169–180 (2001).

    Article  CAS  Google Scholar 

  16. Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335–339 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The New York University and the Rockefeller University, New York, New York

    Nina Bhardwaj

  2. Partners AIDS Research Center Massachusetts General Hospital, and Division of AIDS Harvard Medical School, Boston, Massachusetts, USA

    Bruce D. Walker

Authors
  1. Nina Bhardwaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce D. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhardwaj, N., Walker, B. Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine. Nat Med 9, 13–14 (2003). https://doi.org/10.1038/nm0103-13

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0103-13

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing